RedHill Biopharma reported $33.3B in Ordinary Share Capital for its fiscal quarter ending in June of 2025.





Ordinary Share Capital Change Date
Cara Therapeutics USD 9.38M 9.38M Sep/2025
Clal Biotechnology ILS 1.61M 0 Dec/2022
Compugen USD 94.55M 1.02M Dec/2025
Cronos Group USD 382.89M 286.14M Sep/2025
RedHill Biopharma USD 33.3B 20.4B Jun/2025